Jianming Liang

机构：Guangzhou University of Chinese Medicine, Guangzhou University, First Affiliated Hospital of Guangzhou University of Chinese Medicine · ORCID：0000-0001-6855-7778

发表论文 51 篇 · 总被引 2274 次 · h-index 24

代表论文

• A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease (2022 · Journal of Nanobiotechnology · 被引 73)
• BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC (2022 · Journal of Cancer · 被引 34)
• Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array (2021 · Phytomedicine · 被引 31)
• HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma (2022 · International Journal of Nanomedicine · 被引 30)
• Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer (2022 · Frontiers in Immunology · 被引 26)
• Discovery of Platinum IV –Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents (2023 · Journal of Medicinal Chemistry · 被引 21)